Top

Published in:

01-12-2013 | Clinical and Epidemiological Study

Evaluation of an infectious disease consultation programme in a German tertiary care hospital

Authors: J. J. Vehreschild, G. Morgen, O. A. Cornely, P. Hartmann, S. Koch, W. Kalka-Moll, C. Wyen, M. J. G. T. Vehreschild, C. Lehmann, D. Gillor, H. Seifert, G. Kremer, G. Fätkenheuer, N. Jung

Published in: Infection | Issue 6/2013

Abstract

Purpose

To evaluate a newly implemented infectious disease (ID) consultation service in terms of patient care, outcome and antibiotic prescription and to describe factors influencing adherence to recommendations.

Methods

Data from consultations during the first 6 months of the ID consultation program were collected and evaluated. Consultation requests, diagnostic results, treatment outcomes and antibiotic recommendations were categorised. Diagnostic and therapeutic recommendations were assessed and rated for adherence and outcome. Statistical analysis was performed to identify factors influencing adherence and treatment outcome.

Results

A total of 251 consultations were assessed. In most cases, ID specialists were asked for further advice regarding a previously initiated anti-infective treatment (N = 131, 52 %). In 54 of 195 (28 %) first consultations, the ID specialist proposed a differential diagnosis that differed from that of the working diagnoses submitted with the consultation request, and which was subsequently confirmed in 80 % of these cases. Diagnostic and therapeutic recommendations were made in 190 (76 %) and 240 (96 %) of the consultations, respectively. A change in the current treatment was recommended in 66 % of consultations; 37 % of recommendations were cost-saving and 26 % were cost-neutral. Compliance with diagnostic and therapeutic recommendations was rated as good by pre-specified criteria in 65 and 86 % of consultations, respectively. Treatment outcome was correlated with adherence to diagnostic recommendations (P = 0.012). Twenty-nine patients (16 %) died during the same hospital stay.

Conclusion

Infectious disease consultations may help to establish the correct diagnosis, resulting in the appropriate treatment being provided to a severely sick patient population. Treatment outcome was improved in cases of good diagnostic adherence to the recommendations of the ID specialist.

Available only for authorised users

Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238–45. doi:10.1001/jama.291.10.1238.PubMedCrossRef

Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, et al. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect. 2008;14:144–53. doi:10.1111/j.1469-0691.2007.01850.x.PubMedCrossRef

Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7:629–41. doi:10.1038/nrmicro2200.PubMedCrossRef

Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis. 2007;58:163–70. doi:10.1016/j.diagmicrobio.2006.12.022.PubMedCrossRef

Raineri E, Pan A, Mondello P, Acquarolo A, Candiani A, Crema L. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. Am J Infect Control. 2008;36:283–90. doi:10.1016/j.ajic.2007.06.009.PubMedCrossRef

Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis. 1998;27:478–86.PubMedCrossRef

Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46:1000–8. doi:10.1086/529190.PubMedCrossRef

Robinson JO, Pozzi-Langhi S, Phillips M, Pearson JC, Christiansen KJ, Coombs GW, et al. Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis. 2012;31:2421–8. doi:10.1007/s10096-012-1585-y.PubMedCrossRef

Rieg S, Peyerl-Hoffmann G, de With K, Theilacker C, Wagner D, Hubner J, et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation–a study of 521 patients in Germany. J Infect. 2009;59:232–9. doi:10.1016/j.jinf.2009.07.015.PubMedCrossRef

10.

de La Blanchardiere A, Boutemy J, Thibon P, Michon J, Verdon R, Cattoir V. Clinical benefit of infectious diseases consultation: a monocentric prospective cohort study. Infection. 2012;40:501–7. doi:10.1007/s15010-012-0283-0.PubMedCrossRef

11.

Forsblom E, Ruotsalainen E, Ollgren J, Jarvinen A. Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus Bacteremia. Clin Infect Dis. 2013;56:527–35. doi:10.1093/cid/cis889.PubMedCrossRef

12.

Gomez J, Conde Cavero SJ, Hernandez Cardona JL, Nunez ML, Ruiz Gomez J, Canteras M, et al. The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital. J Antimicrob Chemother. 1996;38:309–14.PubMedCrossRef

13.

LaRocco A Jr. Concurrent antibiotic review programs–a role for infectious diseases specialists at small community hospitals. Clin Infect Dis. 2003;37:742–3. doi:10.1086/377286.PubMedCrossRef

14.

Sellier E, Pavese P, Gennai S, Stahl JP, Labarere J, Francois P. Factors and outcomes associated with physicians’ adherence to recommendations of infectious disease consultations for inpatients. J Antimicrob Chemother. 2010;65:156–62. doi:10.1093/jac/dkp406.PubMedCrossRef

15.

John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis. 1997;24:471–85.PubMedCrossRef

16.

Yinnon AM. Whither infectious diseases consultations? Analysis of 14,005 consultations from a 5-year period. Clin Infect Dis. 2001;33:1661–7. doi:10.1086/323760.PubMedCrossRef

17.

Mondain V, Lieutier F, Hasseine L, Gari-Toussaint M, Poiree M, Lions C, et al. A 6-year antifungal stewardship programme in a teaching hospital. Infection. 2013;. doi:10.1007/s15010-013-0431-1.PubMed

18.

Boulware DR, Dekarske AS, Filice GA. Physician preferences for elements of effective consultations. J Gen Intern Med. 2009;25:25–30. doi:10.1007/s11606-009-1142-2.PubMedCrossRef

19.

Lo E, Rezai K, Evans AT, Madariaga MG, Phillips M, Brobbey W, et al. Why don’t they listen? Adherence to recommendations of infectious disease consultations. Clin Infect Dis. 2004;38:1212–8. doi:10.1086/383315.PubMedCrossRef

20.

Sipahi OR, Tasbakan M, Pullukcu H, Arda B, Yamazhan T, Mizrakci S, et al. Accuracy of consultations performed by infectious diseases trainees and factors associated with adherence to them. Int J Infect Dis. 2007;11:518–23. doi:10.1016/j.ijid.2007.02.003.PubMedCrossRef

21.

Sellier E, Labarere J, Gennai S, Bal G, Francois P, Pavese P. Compliance with recommendations and clinical outcomes for formal and informal infectious disease specialist consultations. Eur J Clin Microbiol Infect Dis. 2011;30:887–94. doi:10.1007/s10096-011-1172-7.PubMedCrossRef

22.

Kim BN. Compliance with an infectious disease specialist’s advisory consultations on targeted antibiotic usage. J Infect Chemother. 2005;11:84–8. doi:10.1007/s10156-004-0365-8.PubMedCrossRef

23.

Pulcini C, Pradier C, Samat-Long C, Hyvernat H, Bernardin G, Ichai C, et al. Factors associated with adherence to infectious diseases advice in two intensive care units. J Antimicrob Chemother. 2006;57:546–50. doi:10.1093/jac/dki483.PubMedCrossRef

24.

Pavese P, Sellier E, Laborde L, Gennai S, Stahl JP, Francois P. Requesting physicians’ experiences regarding infectious disease consultations. BMC Infect Dis. 2011;11:62. doi:10.1186/1471-2334-11-62.PubMedCrossRef

25.

Ceyhan M, Yildirim I, Ecevit C, Aydogan A, Ornek A, Salman N, et al. Inappropriate antimicrobial use in Turkish paediatric hospitals: a multicenter point prevalence survey. Int J Infect Dis. 2009;14:e55–61. doi:10.1016/j.ijid.2009.03.013.PubMedCrossRef

26.

Ingram PR, Seet JM, Budgeon CA, Murray R. Point-prevalence study of inappropriate antibiotic use at a tertiary Australian hospital. Intern Med J. 2012;42:719–21. doi:10.1111/j.1445-5994.2012.02809.x.PubMedCrossRef

27.

Lee CC, Lee CH, Chuang MC, Hong MY, Hsu HC, Ko WC. Impact of inappropriate empirical antibiotic therapy on outcome of bacteremic adults visiting the ED. Am J Emerg Med. 2011;. doi:10.1016/j.ajem.2011.11.010.

28.

Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54:4851–63. doi:10.1128/AAC.00627-10.PubMedCrossRef

29.

Shorr AF, Micek ST, Welch EC, Doherty JA, Reichley RM, Kollef MH. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med. 2011;39:46–51. doi:10.1097/CCM.0b013e3181fa41a7.PubMedCrossRef

30.

Thu TA, Rahman M, Coffin S, Harun-Or-Rashid M, Sakamoto J, Hung NV. Antibiotic use in Vietnamese hospitals: a multicenter point-prevalence study. Am J Infect Control. 2012;40:840–4. doi:10.1016/j.ajic.2011.10.020.

Title: Evaluation of an infectious disease consultation programme in a German tertiary care hospital
Authors: J. J. Vehreschild
G. Morgen
O. A. Cornely
P. Hartmann
S. Koch
W. Kalka-Moll
C. Wyen
M. J. G. T. Vehreschild
C. Lehmann
D. Gillor
H. Seifert
G. Kremer
G. Fätkenheuer
N. Jung
Publication date: 01-12-2013
Publisher: Springer Berlin Heidelberg
Published in: Infection / Issue 6/2013
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI: https://doi.org/10.1007/s15010-013-0512-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2013

Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literature

A one-year prospective study on the antibiotic resistance of E. coli strains isolated in urinary specimens of children hospitalized at the University Pediatric Medical Center in Novi Sad, Serbia

Regression of oral Kaposi’s sarcoma after combination antiretroviral therapy

Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment

Relevance of intracranial hypertension control in the management of Cryptococcus neoformans meningitis related to AIDS

Recurrent infection in the left thumb

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials